SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-12-161539
Filing Date
2012-04-13
Accepted
2012-04-13 07:16:37
Documents
8
Period of Report
2012-04-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d330324d6k.htm 6-K 13652
2 EXHIBIT 99.1 d330324dex991.htm EX-99.1 404136
3 EXHIBIT 99.2 d330324dex992.htm EX-99.2 73556
4 EXHIBIT 99.3 d330324dex993.htm EX-99.3 29458
5 EXHIBIT 99.4 d330324dex994.htm EX-99.4 10134
6 EXHIBIT 99.5 d330324dex995.htm EX-99.5 10154
7 GRAPHIC g330324g53d04.jpg GRAPHIC 10084
8 GRAPHIC g330324g92f10.jpg GRAPHIC 21879
  Complete submission text file 0001193125-12-161539.txt   586409
Mailing Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4
Business Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4 514-336-7800
Theratechnologies Inc. (Filer) CIK: 0001512717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 001-35203 | Film No.: 12757460
SIC: 2834 Pharmaceutical Preparations